Louise B. Russell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Louise B. Russell has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Elmira Valiyeva
1 shared publicationJeffrey L. Carson
1 shared publication
Latest Publications
- Open Access
- 1 September 2005
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 18 (9) , 1241-1242
Reviewer Critique: “An Economic Evaluation of the 2003 ESH-ESC Guidelines for the Management of Mild-to-Moderate Hypertension in Greece”
Stafilas et al compare the cost-effectiveness of five antihypertensive medications, one from each of the major classes, for the Greek health system.1 The motivation for the analysis is that the 2003 European Society of Hypertension–European Society of Cardiology guidelines recommend all classes equally as initial therapy, whereas the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) recommends diuretics.2 The results presented by Stafilas et al support JNC-7: a diuretic, chlorthalidone, is the most cost-effective monotherapy for uncomplicated mild or moderate hypertension.
- 1 September 2005
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 18 (9) , 1241-1242
Open AccessReviewer Critique: “An Economic Evaluation of the 2003 ESH-ESC Guidelines for the Management of Mild-to-Moderate Hypertension in Greece”
Stafilas et al compare the cost-effectiveness of five antihypertensive medications, one from each of the major classes, for the Greek health system.1 The motivation for the analysis is that the 2003 European Society of Hypertension–European Society of Cardiology guidelines recommend all classes equally as initial therapy, whereas the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) recommends diuretics.2 The results presented by Stafilas et al support JNC-7: a diuretic, chlorthalidone, is the most cost-effective monotherapy for uncomplicated mild or moderate hypertension.
- Open Access
- 25 October 2004
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (19) , 2119-2124
Effects of Prehypertension on Admissions and Deaths
On May 14, 2003, the National Heart, Lung, and Blood Institute released new clinical practice guidelines for high blood pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) was published a week later in The Journal of the American Medical Association.1 The guidelines caught the attention of clinicians and the media with 2 changes in particular: they emphasized that systolic blood pressure (SBP), not diastolic BP, was the treatment target, and they defined a new category, “prehypertension,” which includes persons whose SBPs are 120 to 139 mm Hg; frank hypertension begins at 140 mm Hg. Systolic blood pressures in this range were previously considered normal. The new category includes 22% of American adults (approximately 45 million persons).2
- 25 October 2004
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (19) , 2119-2124
Open AccessEffects of Prehypertension on Admissions and Deaths
On May 14, 2003, the National Heart, Lung, and Blood Institute released new clinical practice guidelines for high blood pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) was published a week later in The Journal of the American Medical Association.1 The guidelines caught the attention of clinicians and the media with 2 changes in particular: they emphasized that systolic blood pressure (SBP), not diastolic BP, was the treatment target, and they defined a new category, “prehypertension,” which includes persons whose SBPs are 120 to 139 mm Hg; frank hypertension begins at 140 mm Hg. Systolic blood pressures in this range were previously considered normal. The new category includes 22% of American adults (approximately 45 million persons).2